UCB in brief

UCB aspires to be the patient-centric global biopharmaceutical leader, transforming the lives of people living with serious diseases.

The company employs more than 8 500 people dedicated to the research, development and commercialisation of innovative medicines and patient solutions.

Operating in more than 40 countries, UCB generated revenues of € 3.2 billion in 2010.